Search filters

Filters
Clear All

Phase

  • 4
  • 4
  • 6
  • 15
  • 3
  • 15

Found 15 dm-gastroenterology trials

A listing of dm-gastroenterology medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis
18 years - 70 years
All genders
Phase 3
Interventional
To investigate the safety and efficacy of Tradipitant versus placebo in relieving nausea and other symptoms of gastroparesis.
18 years - 69 years
All genders
Phase 2
Are you still experiencing celiac disease symptoms despite your best efforts to follow a gluten-free diet?The goal of this phase 2 clinical trial is to test the safety and effects of the investigational medication PRV-015. In combination with a gluten-free diet, PRV-015 aims to reduce symptoms and intestinal inflammation caused …
 Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
18 years - 99 years
All genders
Phase 3
This study investigates non-alcoholic steatohepatitis (NASH).The study evaluates the effects of an investigational medication on NASH.Who can participate: Adults aged 18 or older with histological evidence of NASH, both male and female, can participate.Study details: Participants will inject the investigational medication under their skin once a week. An inactive substance …
 RevitaT2Di Pivotal Study (REVITALIZE 1)
21 years - 70 years
All genders
This study investigates a procedure called duodenal mucosal resurfacing (DMR) for individuals with Type 2 Diabetes. The DMR procedure targets the mucosa, the first layer of the duodenum, which is part of the small intestine located immediately after the stomach.The study evaluates whether the DMR procedure can improve blood sugar …
18 years - 70 years
All genders
Are you between the ages of 18-70? Do you have an ileostomy? You may be eligible for this study!
 A multicenter  double-blind  randomized  placebo-controlled trial to evaluate the efficacy and safety of apraglutide in adult subjects with short bowel syndrome and intestinal failure (SBS-IF)
18 years - 100 years
All genders
Phase 3
Interventional
The purpose of this study is to find out if the investigational drug, apraglutide and investigational drug , is able to reduce the volume per week of PS required in adults with short bowel syndrome and intestinal failure.
 Evaluating the Safety and Tolerability of XmAb 18087 in Subjects with Advanced Neuroendocrine and Gastrointestinal Stromal Tumors (DUET-1)
12 years - 99 years
All genders
The primary purposes of this research study is to determine the safety and tolerability of the investigational drug, XmAb18087, and if the XmAb18087 works in treating tumors like you have and side effects from XmAb18087, to find the best dose for treating your type of tumor. XmAb18087 is an investigational …
 Trial to evaluate the efficacy of Dupilumab in Eosinophilic Gastritis
12 years - 70 years
All genders
Phase 2
Interventional
To assess the efficacy of repeat subcutaneous (SC) doses of dupilumab, compared with placebo, to reduce eosinophilic inflammation in the stomach of participants with eosinophilic gastritis (EG)/ eosinophilic gastroenteritis (EGE).
 An induction and maintenance study to evaluate the efficacy and safety of cc-93538 in adult and adolescent subjects with eosinophilic esophagitis.
12 years - 75 years
All genders
Phase 3
Interventional
Eosinophilic Esophagitis is a chronic, allergic, inflammatory disorder of the esophagus . The allergic substance, which is called an, ‘allergen’, is often not known, and there may be more than one allergen causing your condition. For people with Eosinophilic Esophagitis, the allergen is usually something in the diet, or something …
 TARGET-PBC: A 5-year Longitudinal Observational Study of Patients with Primary Biliary Cholangitis
18 years - 80 years
All genders
You are being asked to be in this research study because you have PBC (primary biliary cholangitis) which is an uncommon chronic cholestatic liver disease characterized by progressive inflammation and destruction of the interlobular bile ducts, ultimately leading to the development of biliary cirrhosis. 
1 - 10 of 15